R.H. Bluestein & Co’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $43.8M | Sell |
86,416
-2,913
| -3% | -$1.63M | 2.73% | 9 |
|
|
2022
Q2 | $48.5M | Sell |
89,329
-1,139
| -1% | -$627K | 2.98% | 7 |
|
|
2022
Q1 | $53.4M | Sell |
90,468
-8,340
| -8% | -$4.79M | 2.24% | 13 |
|
|
2021
Q4 | $65.9M | Sell |
98,808
-1,353
| -1% | -$845K | 2.36% | 8 |
|
|
2021
Q3 | $57.2M | Buy |
100,161
+3,040
| +3% | +$1.67M | 2.27% | 13 |
|
|
2021
Q2 | $49M | Buy |
97,121
+5,352
| +6% | +$2.53M | 1.9% | 17 |
|
|
2021
Q1 | $41.9M | Sell |
91,769
-3,825
| -4% | -$1.83M | 1.77% | 21 |
|
|
2020
Q4 | $44.5M | Buy |
95,594
+2,964
| +3% | +$1.39M | 1.98% | 11 |
|
|
2020
Q3 | $40.9M | Buy |
92,630
+21,613
| +30% | +$8.93M | 2.05% | 13 |
|
|
2020
Q2 | $25.7M | Buy |
71,017
+4,699
| +7% | +$1.58M | 1.44% | 15 |
|
|
2020
Q1 | $18.8M | Buy |
66,318
+62,266
| +1,537% | +$19.6M | 1.6% | 19 |
|
|
2019
Q4 | $1.32M | Buy |
4,052
+600
| +17% | +$182K | 0.07% | 63 |
|
|
2019
Q3 | $1M | Buy |
3,452
+700
| +25% | +$200K | 0.06% | 70 |
|
|
2019
Q2 | $808K | Buy |
2,752
+1,300
| +90% | +$358K | 0.04% | 84 |
|
|
2019
Q1 | $397K | Hold |
1,452
| – | – | 0.02% | 167 |
|
|
2018
Q4 | $325K | Sell |
1,452
-300
| -17% | -$70.4K | 0.03% | 164 |
|
|
2018
Q3 | $428K | Sell |
1,752
-1,800
| -51% | -$414K | 0.02% | 195 |
|
|
2018
Q2 | $736K | Sell |
3,552
-3,000
| -46% | -$637K | 0.04% | 107 |
|
|
2018
Q1 | $1.35M | Buy |
6,552
+4,998
| +322% | +$1.05M | 0.07% | 67 |
|
|
2017
Q4 | $295K | Buy |
1,554
+2
| +0.1% | +$383 | 0.02% | 247 |
|
|
2017
Q3 | $294K | Hold |
1,552
| – | – | 0.02% | 252 |
|
|
2017
Q2 | $271K | Sell |
1,552
-2,350
| -60% | -$395K | 0.02% | 242 |
|
|
2017
Q1 | $599K | Buy |
3,902
+1,675
| +75% | +$256K | 0.04% | 119 |
|
|
2016
Q4 | $314K | Sell |
2,227
-100
| -4% | -$14.7K | 0.02% | 207 |
|
|
2016
Q3 | $370K | Buy |
2,327
+152
| +7% | +$23.4K | 0.02% | 154 |
|
|
2016
Q2 | $321K | Sell |
2,175
-7,200
| -77% | -$1.06M | 0.02% | 171 |
|
|
2016
Q1 | $1.33M | Buy |
+9,375
| New | +$1.26M | 0.1% | 57 |
|
|
2015
Q2 | – | Sell |
-253,087
| Closed | -$34M | – | 353 |
|
|
2015
Q1 | $34M | Sell |
253,087
-24,782
| -9% | -$3.19M | 2.05% | 17 |
|
|
2014
Q4 | $34.8M | Buy |
277,869
+13,806
| +5% | +$1.68M | 2.18% | 11 |
|
|
2014
Q3 | $32.1M | Buy |
264,063
+7,551
| +3% | +$918K | 2.01% | 21 |
|
|
2014
Q2 | $30.3M | Buy |
256,512
+54,709
| +27% | +$6.44M | 1.8% | 25 |
|
|
2014
Q1 | $24.3M | Buy |
201,803
+168,028
| +497% | +$20M | 1.6% | 26 |
|
|
2013
Q4 | $3.76M | Buy |
33,775
+17,775
| +111% | +$1.77M | 0.24% | 61 |
|
|
2013
Q3 | $1.47M | Buy |
+16,000
| New | +$1.45M | 0.1% | 80 |
|
Other funds holding TMO
R.H. Bluestein & Co's TMO Position: Q3 2022 in Review
R.H. Bluestein & Co reduced its Thermo Fisher Scientific (TMO) stake by 3.3% in Q3 2022, selling an estimated $1.63M and leaving 86,416 shares worth $43.8M. The position accounts for 2.73% of the portfolio, ranked #9.
R.H. Bluestein & Co first reported a position in TMO in Q3 2013 and has held it in 34 quarters since. The position peaked at $65.9M in Q4 2021. 2,266 funds tracked by Wall St. Rank hold TMO as of Q3 2022.
- R.H. Bluestein & Co held 86,416 shares of Thermo Fisher Scientific worth $43.8M as of Q3 2022.
- R.H. Bluestein & Co sold 2,913 Thermo Fisher Scientific shares in Q3 2022, an estimated $1.63M.
- Thermo Fisher Scientific made up 2.73% of R.H. Bluestein & Co's portfolio in Q3 2022, its #9 holding.
- R.H. Bluestein & Co first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 34 quarters since.
- R.H. Bluestein & Co's Thermo Fisher Scientific position peaked at $65.9M in Q4 2021.
- 2,266 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.
Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.